| Krikorian, Robert |
| Active, not recruiting | N/A | 250 | US | Berry fruit powder OR nutritional ketosis, Placebo powder OR higher carbohydrate | University of Cincinnati | Overweight, Obesity and Other Hyperalimentation (E65-E68) | 12/24 | 12/24 | | |
NCT06027320: The Retain Your Brain Health Study (RetainYourBrain.com) |
|
|
| Completed | N/A | 992 | US | Brain Health Education, Alzheimer Disease Education | Retain Health, Inc, National Institute on Aging (NIA) | Alzheimer Disease, Dementia, Healthy Participants, Brain Health | 09/24 | 09/24 | | |
| Arnold, Lesley M |
| Completed | 3 | 275 | US | Digital ACT, Digital Symptom Tracker | Swing Therapeutics, Inc. | Fibromyalgia | 05/23 | 05/23 | | |
| Broderick, Joseph P |
| Recruiting | 3 | 860 | Europe, Canada, Japan, US | Recombinant Activated Factor VII (rFVIIa), NovoSeven, NiaStase, Placebo | Joseph Broderick, MD, Novo Nordisk A/S, National Institute of Neurological Disorders and Stroke (NINDS) | Intracerebral Hemorrhage | 01/28 | 01/28 | | |
| Recruiting | N/A | 20000 | Europe, Canada, US | | University Hospital, Geneva, University of Geneva, Switzerland, Klinik Hirslanden, Zurich | Intracranial Aneurysm | 03/40 | 03/40 | | |
| Bernstein, Jonathan A |
NCT06690047: Treatment of Hereditary Angioedema Prodrome with Recombinant C1-esterase Inhibitor (Ruconest) |
|
|
| Completed | 4 | 5 | US | Ruconest | Bernstein Clinical Research Center | Hereditary Angioedema | 04/22 | 04/22 | | |
NCT04358224: The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment |
|
|
| Completed | 4 | 12 | US | Dupilumab Prefilled Syringe, dupixent | Jonathan A. Bernstein, MD | Atopic Dermatitis, Eczema | 11/22 | 11/22 | | |
CALM-CSU, NCT06077773: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria |
|
|
| Recruiting | 2 | 154 | Europe, Canada, US | Oral EP262, Placebo | Escient Pharmaceuticals, Inc | Chronic Spontaneous Urticaria | 06/25 | 07/25 | | |
| Active, not recruiting | 1/2 | 44 | Europe, US, RoW | Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331, Dose 4 of BMN 331, Dose 5 of BMN 331, Dose 6 of BMN 331, Dose 7 of BMN 331 | BioMarin Pharmaceutical, BioMarin Pharmaceutical Inc. | Hereditary Angioedema, HAE | 11/28 | 11/28 | | |
CALM-CIndU, NCT06050928: Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria |
|
|
| Completed | 1 | 33 | Europe, Canada, US | Oral EP262 | Escient Pharmaceuticals, Inc | Chronic Inducible Urticaria | 10/24 | 10/24 | | |
NCT04583007: Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults |
|
|
| No Longer Available | N/A | | Europe, Canada, US | Lanadelumab 150 mg, TAK-743, SHP643, DX-2930, Lanadelumab 300 mg | Shire, Takeda Development Center Americas, Inc. | Hereditary Angioedema (HAE), Angioedema | | | | |
NCT00898755: Collecting and Storing Tissue From Young Patients With Cancer |
|
|
| Active, not recruiting | N/A | 213 | Canada, US | Cytology Specimen Collection Procedure, Cytologic Sampling, Laboratory Biomarker Analysis | Children's Oncology Group, National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, Ewing Sarcoma, Germ Cell Tumor, Leukemia, Lymphoma, Malignant Neoplasm, Neuroblastoma, Osteosarcoma, Retinoblastoma, Rhabdoid Tumor, Rhabdomyosarcoma, Soft Tissue Sarcoma | 12/25 | 12/25 | | |
NCT02450851: Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network |
|
|
| Recruiting | N/A | 20000 | US | | National Human Genome Research Institute (NHGRI) | Genetic Disease | 12/28 | 12/28 | | |
| Fichtenbaum, Carl J |
| Active, not recruiting | 3 | 719 | Japan, US, RoW | Tecovirimat Oral Capsule, Placebo, Tecovirimat Oral Capsule (Open Label) | National Institute of Allergy and Infectious Diseases (NIAID), SIGA Technologies | MPOX | 10/24 | 09/25 | | |
EMBRACE, NCT05996471: A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir Compared to Standard of Care (SOC) in Male and Female Adults Living With Human Immunodeficiency Virus (HIV) |
|
|
| Active, not recruiting | 2 | 128 | US | VH3810109, Cabotegravir, Standard of care (SOC), rHuPH20 | ViiV Healthcare | HIV Infections | 11/24 | 05/26 | | |
NCT06741397: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a New Formulation of Cabotegravir Long-Acting Administered Intramuscularly in a 4-month Dosing Interval (Q4M) |
|
|
| Not yet recruiting | 2 | 200 | US | CAB LA, New formulation of CAB LA | ViiV Healthcare | HIV Infections | 08/26 | 12/28 | | |
NCT05630885: A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV |
|
|
| Completed | 2 | 110 | US | CVC 150 mg, CVC 300 mg, Placebo for CVC 150 mg, Placebo for CVC 300 mg | National Institute of Allergy and Infectious Diseases (NIAID), AbbVie | HIV-1-infection | 06/24 | 06/24 | | |
| Recruiting | 2 | 250 | US | Doxycycline, Placebo | Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, University of Iowa, University of Michigan | Emphysema, HIV | 02/27 | 02/27 | | |
| Completed | 1/2 | 30 | US | SB-728-T, Expanded unmodified autologous CD4+ T cells | University of Cincinnati, University of California, San Francisco, Case Western Reserve University | HIV Infections | 01/24 | 02/24 | | |
| Strawn, Jeffrey R |
| Recruiting | 4 | 60 | US | Duloxetine, Cymbalta, Irenka, Escitalopram, Lexapro | University of Cincinnati | Anxiety, Depressive Symptoms | 07/25 | 08/25 | | |
| Recruiting | 4 | 84 | US | Escitalopram, Lexapro, Duloxetine, Cymbalta | University of Cincinnati | Anxious Depression, Depression | 07/25 | 12/25 | | |
EV-SoPRANO, NCT04221997: Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders. |
|
|
| Recruiting | 4 | 150 | US | sertraline, Zoloft | University of Cincinnati, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Anxiety Disorders | 09/26 | 09/26 | | |
PrEcISE, NCT04623099: Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy |
|
|
| Recruiting | 4 | 132 | US | Escitalopram, Lexapro | University of Cincinnati, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Anxiety | 06/26 | 12/26 | | |
| Shah, Shimul |
| Terminated | N/A | 246 | US | | CareDx | Transplant | 02/23 | 07/23 | | |
PILOTâ„¢_CA, NCT05574361: Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA) |
|
|
| Recruiting | N/A | 120 | US | Hypothermic Machine Perfusion | Organ Recovery Systems, Inc. | Liver Transplantation | 12/24 | 12/25 | | |
| Active, not recruiting | N/A | 1500 | US | LiverCare | CareDx | Liver Transplantation, Biomarkers | 12/27 | 03/28 | | |
| Grawe, Brian |
NCT06269705: ZILRETTA in Subjects with Shoulder Osteoarthritis |
|
|
| Recruiting | 3 | 250 | US | ZILRETTA, TCA-IR, Placebo, Normal Saline | Pacira Pharmaceuticals, Inc | Glenohumeral Osteoarthritis | 08/25 | 08/25 | | |
NCT05560477: Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing |
|
|
| Recruiting | 1/2 | 74 | US | AM3101, Saline Placebo | University of Cincinnati, United States Department of Defense | Meniscus Tear | 01/24 | 06/24 | | |
NCT05876208: Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform |
|
|
| Recruiting | N/A | 60 | US | BAND Connect's VirtuaCare™ platform, Standard of Care Physical Therapy | University of Cincinnati | Shoulder Injuries | 07/24 | 12/24 | | |
| Hasselfield, Kimberly |
| Completed | 2 | 76 | US | VT-X7 Treatment System, Two-stage exchange arthroplasty, SOC Antibiotics, Experimental Antibiotics | Osteal Therapeutics, Inc. | Prosthetic-joint Infection | 05/24 | 10/24 | | |
| Rodriguez, Carolina V Alexander |
| Completed | 3 | 13 | US | Inhaled Nitric Oxide, Placebo | University of Cincinnati | Traumatic Brain Injury | 12/23 | 12/23 | | |
| Recruiting | N/A | 400 | Canada, US | Albumin Human, albumin | American Burn Association, United States Department of Defense | Burn Injury | 08/25 | 09/25 | | |
| Reinert, Becky |
NCT03187925: Cricopharyngeal Dysfunction and Esophageal Diverticulum |
|
|
| Recruiting | N/A | 500 | US | open, transcervical versus rigid endoscopic treatment, observation | University of Cincinnati | Zenker Diverticulum, Progressive Dysphagia, Pharyngoesophageal Diverticulum | 06/27 | 06/27 | | |
| Margiotti, Regina |
| Recruiting | 4 | 250 | US | Bromocriptine, Parlodel, Cycloset, Placebo, Guideline Directed Medical Therapy for Heart Failure (GDMT), Rivaroxaban, Xarelto, Second Placebo | Dennis M. McNamara, MD, MS, National Heart, Lung, and Blood Institute (NHLBI) | Peripartum Cardiomyopathy, Postpartum | 06/26 | 12/28 | | |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
COMPETENCE, NCT01187368: Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System |
|
|
| Suspended | N/A | 399 | US | EVAHEART Left Ventricular Assist System (LVAS), EVA2, HeartMate 3, HM3 | Evaheart, Inc. | Heart Failure | 07/27 | 07/28 | | |
NCT03523416: Early Feasibility Study - Edwards APTURE Transcatheter Shunt System |
|
|
| Active, not recruiting | N/A | 71 | US | Transcatheter Atrial Shunt System | Edwards Lifesciences | Heart Failure | 12/23 | 11/28 | | |
| Hasselfeld, Kimberly |
NCT06269705: ZILRETTA in Subjects with Shoulder Osteoarthritis |
|
|
| Recruiting | 3 | 250 | US | ZILRETTA, TCA-IR, Placebo, Normal Saline | Pacira Pharmaceuticals, Inc | Glenohumeral Osteoarthritis | 08/25 | 08/25 | | |
NCT05560477: Study to Evaluate the Safety and Efficacy of AM3101 to Augment Meniscal Healing |
|
|
| Recruiting | 1/2 | 74 | US | AM3101, Saline Placebo | University of Cincinnati, United States Department of Defense | Meniscus Tear | 01/24 | 06/24 | | |
NCT04015154: A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail PF |
|
|
| Recruiting | N/A | 60 | US | Femoral Nail PF of the T2 Alpha Femur Antegrade GT/PF Nailing System | Stryker Trauma and Extremities | Femoral Fracture | 06/25 | 06/25 | | |
NCT04015128: A Post-Market Clinical Evaluation of the Treatment of Femur Fractures With the Femoral Nail GT |
|
|
| Recruiting | N/A | 60 | US | Femoral Nail GT of the T2 Alpha Femur Antegrade GT/PF Nailing System | Stryker Trauma and Extremities | Femoral Fracture | 12/24 | 12/24 | | |
| Mardis, Rachel |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
| Active, not recruiting | N/A | 457 | Europe, US | Cordella™ Pulmonary Artery Sensor System | Endotronix, Inc. | Heart Failure NYHA Class III | 04/28 | 04/28 | | |
| Kant, Kotagal |
| Terminated | 3 | 667 | Europe, Japan, US, RoW | Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule | Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC | Autosomal Dominant Polycystic Kidney, ADPKD | 08/23 | 08/23 | | |
| Prystowsky, Eric |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
| Afzali, Anita |
ASSIST, NCT05316584: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy |
|
|
| Active, not recruiting | N/A | 123 | US | Remote monitoring | University of Maryland, Baltimore, University of North Carolina, Chapel Hill, Vanderbilt University Medical Center, New York University, University of Cincinnati, Synchronyx, LLC | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 07/25 | 07/25 | | |
| Becker, Richard |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
| Dale, Elizabeth |
| Recruiting | N/A | 400 | Canada, US | Albumin Human, albumin | American Burn Association, United States Department of Defense | Burn Injury | 08/25 | 09/25 | | |
NCT05325996: Evaluating Home Testing Devices for the Management of Glaucoma |
|
|
| Recruiting | N/A | 50 | US | Standard Automatic Perimetry Humphrey Field Analyzer, SAP HFA, visuALL H, iCare Home Tonometer, Spectralis Optical coherence tomography (OCT) | Wills Eye | Glaucoma, Open-Angle | 12/26 | 12/26 | | |
| Awosika, Oluwole |
| Completed | 2 | 129 | US | Sham, Low dose tDCS, High dose tDCS, mCIMT | Duke University, National Institute of Neurological Disorders and Stroke (NINDS) | Stroke, Ischemic, Motor Activity, Upper Extremity Paralysis | 09/24 | 09/24 | | |
BLT2, NCT04553198: Quantifying the Role of Sensory Systems Processing in Post-Stroke Walking Recovery |
|
|
| Completed | N/A | 44 | US | Backward Locomotion Treadmill Training (BLTT) | University of Cincinnati, American Academy of Neurology | Stroke, Chronic Stroke, Walking, Difficulty, Gait, Hemiplegic | 01/23 | 01/23 | | |
| Completed | N/A | 18 | US | Backward Locomotion Treadmill Training (BLTT), Forward Locomotion Treadmill Training (FLTT) | University of Cincinnati | Stroke, Chronic Stroke, Walking, Difficulty, Gait, Hemiplegic | 06/24 | 06/24 | | |
| Recruiting | N/A | 45 | US | Posturography, mCITSIB, Walking Speed, 10 Meter Walk Test, Instrumented 7M Timed UP and GO, iTUG, Fall Event Records, MRI (3T) | University of Cincinnati, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Ischemic Stroke | 08/26 | 08/26 | | |
| Ngwenya, Laura B |
| Terminated | 2 | 92 | Europe, Japan, US, RoW | BIIB093, Glibenclamide, CIRARA, RP 1127, Placebo | Remedy Pharmaceuticals, Inc. | Brain Contusion | 06/23 | 06/23 | | |
NCT04836481: A Pharmacokinetic Analysis of Levetiracetam Prophylaxis in Critically Ill Patients With Severe Traumatic Brain Injury |
|
|
| Completed | N/A | 10 | US | Serum Sample Collection | University of Cincinnati, American College of Clinical Pharmacy | Traumatic Brain Injury | 05/22 | 10/23 | | |
| Sagi, Henry C |
NCT04860856: Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial |
|
|
| Completed | 4 | 88 | US | 0.5% ropivacaine, Normal Saline | University of Cincinnati | Femur Fracture | 02/23 | 02/23 | | |
NCT06409559: Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws |
|
|
| Recruiting | N/A | 60 | US | pelvic reconstruction, interfragmentary screws placed through the plate, buttress plate applied under compression without interfragmentary lag or position screws | University of Cincinnati | Acetabular Fracture | 03/25 | 03/26 | | |
NCT04389749: Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures |
|
|
| Recruiting | N/A | 100 | US | CPM | University of Cincinnati | Fractures, Bone | 06/25 | 06/26 | | |
| Durante, Marisa |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
C-TRACT, NCT03250247: Chronic Venous Thrombosis: Relief With Adjunctive Catheter-Directed Therapy (The Trial) |
|
|
| Recruiting | N/A | 250 | US | Stents | Washington University School of Medicine, Ontario Clinical Oncology Group (OCOG), Massachusetts General Hospital, Saint Luke's Mid America Heart Institute | Deep Vein Thrombosis, Venous Stasis, Venous Insufficiency, Venous Leg Ulcer, Venous Reflux, Post Thrombotic Syndrome | 01/26 | 04/26 | | |
DISRUPT-AF, NCT06335082: A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF |
|
|
| Enrolling by invitation | N/A | 2000 | US | Pulsed Field Ablation | Heart Rhythm Clinical and Research Solutions, LLC, Boston Scientific Corporation | Atrial Fibrillation | 11/26 | 01/27 | | |
NCT04088071: Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation |
|
|
| Recruiting | N/A | 15000 | US | Catheter ablation | Heart Rhythm Clinical and Research Solutions, LLC, Biosense Webster, Inc. | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation | 12/27 | 12/27 | | |
| S, He C |
NCT04860856: Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial |
|
|
| Completed | 4 | 88 | US | 0.5% ropivacaine, Normal Saline | University of Cincinnati | Femur Fracture | 02/23 | 02/23 | | |
| Hasselfeld, Kim |
NCT04860856: Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial |
|
|
| Completed | 4 | 88 | US | 0.5% ropivacaine, Normal Saline | University of Cincinnati | Femur Fracture | 02/23 | 02/23 | | |
NCT05357079: Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin/Hematocrit |
|
|
| Recruiting | 1 | 98 | US | Tranexamic Acid, Cyklokapron, Pfizer, Normal saline | University of Cincinnati, Foundation for Orthopedic Trauma | Fracture of Posterior Wall of Acetabulum | 08/25 | 12/25 | | |
NCT06409559: Rim Plate to Buttress Plate for Posterior Wall Acetabular Fractures With and Without Inter-fragmentary Screws |
|
|
| Recruiting | N/A | 60 | US | pelvic reconstruction, interfragmentary screws placed through the plate, buttress plate applied under compression without interfragmentary lag or position screws | University of Cincinnati | Acetabular Fracture | 03/25 | 03/26 | | |
NCT05223777: KINCISEâ„¢ Surgical Automated System in Total Hip Arthroplasty (THA) |
|
|
| Recruiting | N/A | 50 | US | KINCISE, Traditional Handheld Mallet | University of Cincinnati | Osteoarthritis, Hip | 09/23 | 09/24 | | |
NCT05876208: Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform |
|
|
| Recruiting | N/A | 60 | US | BAND Connect's VirtuaCare™ platform, Standard of Care Physical Therapy | University of Cincinnati | Shoulder Injuries | 07/24 | 12/24 | | |
NCT04389749: Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures |
|
|
| Recruiting | N/A | 100 | US | CPM | University of Cincinnati | Fractures, Bone | 06/25 | 06/26 | | |
| Sedaghat, Ahmad R |
NCT06338995: A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP) |
|
|
| Recruiting | 3 | 510 | Europe, Canada, Japan, US, RoW | LY3650150, Placebo, Standard therapy for INCS | Eli Lilly and Company | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 10/26 | 02/27 | | |
| Raju, Sarath |
| Recruiting | 2 | 250 | US | Doxycycline, Placebo | Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, University of Iowa, University of Michigan | Emphysema, HIV | 02/27 | 02/27 | | |
| Kubasiak, John |
| Recruiting | N/A | 400 | Canada, US | Albumin Human, albumin | American Burn Association, United States Department of Defense | Burn Injury | 08/25 | 09/25 | | |
| Felice, Kara De |
NCT06045754: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease |
|
|
| Recruiting | 4 | 150 | Canada, US | Vedolizumab, Entyvio, Adalimumab, Humira, Ustekinumab, Stelara | Takeda | Crohn's Disease | 06/27 | 06/27 | | |
NCT06095128: A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC) |
|
|
| Recruiting | 4 | 65 | Canada, US | Vedolizumab, Entyvio, MLN0002, Tofacitinib, Xeljanz, CP-690, CP-550 | Takeda | Ulcerative Colitis | 07/27 | 07/27 | | |
ASSIST, NCT05316584: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy |
|
|
| Active, not recruiting | N/A | 123 | US | Remote monitoring | University of Maryland, Baltimore, University of North Carolina, Chapel Hill, Vanderbilt University Medical Center, New York University, University of Cincinnati, Synchronyx, LLC | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 07/25 | 07/25 | | |
MONITOR, NCT06750731: Study of Efficacy and Adherence to Subcutaneous Vs. Intravenous Vedolizumab in Patients with Inflammatory Bowel Disease Using a Novel Remote ing Intervention |
|
|
| Not yet recruiting | N/A | 200 | US | Tappt | Mercy Medical Center, Takeda | Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis | 09/26 | 09/26 | | |
| Henry, Renee |
ASSIST, NCT05316584: A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy |
|
|
| Active, not recruiting | N/A | 123 | US | Remote monitoring | University of Maryland, Baltimore, University of North Carolina, Chapel Hill, Vanderbilt University Medical Center, New York University, University of Cincinnati, Synchronyx, LLC | Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis | 07/25 | 07/25 | | |
MONITOR, NCT06750731: Study of Efficacy and Adherence to Subcutaneous Vs. Intravenous Vedolizumab in Patients with Inflammatory Bowel Disease Using a Novel Remote ing Intervention |
|
|
| Not yet recruiting | N/A | 200 | US | Tappt | Mercy Medical Center, Takeda | Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis | 09/26 | 09/26 | | |
| Renick, Ann |
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation |
|
|
| Recruiting | 3 | 5350 | US | AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy | Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI) | Atrial Fibrillation | 07/29 | 07/29 | | |
| Fewster, Michele |
NCT05979415: Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes |
|
|
| Terminated | 2 | 8 | US | Apomorphine Cartridge, placebo | Alexza Pharmaceuticals, Inc., Peachtree BioResearch Solutions, DSG, ISS, Inc. | Parkinson Disease | 02/24 | 02/24 | | |
| Recruiting | 2 | 87 | US | AAV2-GDNF Gene therapy, Biological, Control Surgery | AskBio Inc, Bayer | Parkinson Disease | 11/27 | 11/27 | | |
NCT05923866: A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy |
|
|
| Recruiting | 2 | 80 | US | ONO-2808, Placebo | Ono Pharmaceutical Co. Ltd | Multiple System Atrophy (MSA) | 08/25 | 08/25 | | |
| Zifodya, Jerry |
| Recruiting | 2 | 250 | US | Doxycycline, Placebo | Weill Medical College of Cornell University, National Heart, Lung, and Blood Institute (NHLBI), University of California, Los Angeles, University of Iowa, University of Michigan | Emphysema, HIV | 02/27 | 02/27 | | |
